Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$885.00M$885.00Mderived+2.4% vs Q4 2024 Net Income-$15.00M-$15.00MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$110,200,000−13.3% Operating Cash Flowderived$103,400,000−7.2% Free Cash Flowderived$90,600,000+1.7% Margins · derivedOperating margin12.5%−2.3 pt vs Q4 2024
Net margin-1.7%+10.9 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 2, 2026 · 61 d after period end